Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.95 USD | -1.99% | -5.53% | +48.30% |
05-08 | Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-07 | Piper Sandler Upgrades Design Therapeutics to Overweight From Neutral | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.30% | 228M | |
+44.14% | 56.87B | |
+38.34% | 39.72B | |
-6.33% | 39.27B | |
-4.42% | 28.73B | |
+13.58% | 26.21B | |
-17.54% | 19.79B | |
+31.53% | 12.28B | |
+27.86% | 12.23B | |
-0.42% | 12.12B |
- Stock Market
- Equities
- DSGN Stock
- News Design Therapeutics, Inc.
- Wedbush Cuts Design Therapeutics' PT to $19 From $26, Pushes Back Expected Market Entry of DT-216 to 2026 After Trial Results; Keeps Outperform Rating